Since the discovery of the human T-cell leukemia virus-1 (HTLV-1), cellular and animal
models have provided invaluable contributions in the knowledge of viral infection …

Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of both adult T-cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T-cell leukemia virus-1 (HTLV-1) is a neglected and incurable retrovirus estimated to
infect 5 to 10 million worldwide. Specific indigenous Australian populations report infection …

Abstract Background The Human T-cell Lymphotropic Virus Type-1 (HTLV-1) is a blood-
borne pathogen and etiological agent of Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV …

Human T cell leukemia virus type 1 (HTLV-1) is a human retrovirus that is associated with
two main diseases: HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …

Genetic alterations in adult T‐cell leukemia/lymphoma (ATLL), a T‐cell malignancy
associated with HTLV‐1, and their clinical impacts, especially from the perspective of viral …

Human T-cell lymphotropic virus type 1 (HTLV-1) infects 5–10 million people worldwide and
is the causative agent of adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated …

Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a neurological disorder presenting with spastic paraparesis …

Background Although Japan is a major endemic area for human T-lymphotropic virus type 1
(HTLV-1) and the virus has been well-studied in this region, there is limited research on …